Company Encyclopedia
View More
name
BAIJIN LIFE SCI
01466.HK
Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale distribution of jewelry products. The company operates through three segments: Jewellery Business, Strategic Investment, and Skincare Business. It is involved in the real estate financial assets investment business. The company also offers skincare solutions under the FO brand name; franchise licensing and consultation services; consultation and research and development services; skincare testing products; and scientific and pharmaceutical research services.
799.86 B
01466.HKMarket value -Rank by Market Cap -/-

Financial Score

27/12/2025 Update
B
Apparel, Accessories and Luxury GoodsIndustry
Industry Ranking28/89
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE7.11%B
    • Profit Margin6.75%B
    • Gross Margin15.39%D
  • Growth ScoreA
    • Revenue YoY20.46%B
    • Net Profit YoY171.18%A
    • Total Assets YoY19.00%A
    • Net Assets YoY46.89%A
  • Cash ScoreB
    • Cash Flow Margin1481.95%B
    • OCF YoY20.46%B
  • Operating ScoreC
    • Turnover0.46C
  • Debt ScoreC
    • Gearing Ratio43.97%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BAIJIN LIFE SCI and Youhuan Bio signed a strategic cooperation framework agreement

    BAIJIN LIFE SCI and YouHuan Bio signed a strategic cooperation framework agreement

    AASTOCKS·
    HK
    01466
    +1.96%
    AASTOCKS·
    HK
    01466
    +1.96%

    BAIJIN LIFE SCI issued 119.9 million shares due to the conversion of convertible bonds

    BAIJIN LIFE SCI announced that, due to receiving a conversion notice from bondholders regarding convertible bonds, the company will issue 119.9 million new shares at a conversion price of HKD 0.2628 per share. The shares being issued represent approximately 15.52% of the company's existing issued share capital and about 13.43% of the enlarged share capital after the issuance. The new shares will be allocated on October 8, 2025

    Zhitong·
    HK
    01466
    +1.96%
    Zhitong·
    HK
    01466
    +1.96%

    BAIJIN LIFE SCI plans to issue 40 million subscription shares at a discount of approximately 14.29%, raising a net amount of about HKD 19.1 million

    BAIJIN LIFE SCI announced that it will issue 40 million subscription shares at a price of HKD 0.48 per share, representing a discount of approximately 14.29%, lower than the closing price of HKD 0.56 on September 29, 2025. This subscription is expected to raise approximately HKD 19.1 million in net proceeds, which will be used for the company's general working capital

    Zhitong·
    HK
    01466
    +1.96%
    Zhitong·
    HK
    01466
    +1.96%

    BAIJIN LIFE SCI will resume trading on July 28

    According to the Zhitong Finance APP, BAIJIN LIFE SCI announced that the company's shares will resume trading at 9:00 AM on July 28, 2025

    Zhitong·
    HK
    01466
    +1.96%
    Zhitong·
    HK
    01466
    +1.96%

    In the "Performance" report, BAIJIN LIFE SCI narrowed its annual loss to 320,000 yuan, and its shares resumed trading

    BAIJIN LIFE SCI announced its financial results for the fiscal year ending in March, with revenue recorded at 136 million yuan, an increase of 152.5% year-on-year. The loss narrowed from 7.45 million yuan in the previous year to 320,000 yuan, with a loss per share of 0.05 cents. No dividend will be distributed. The company's shares have applied to resume trading on Monday (28th)

    AASTOCKS·
    HK
    01466
    +1.96%
    AASTOCKS·
    HK
    01466
    +1.96%
    © 2025 Longbridge｜Disclaimer